OptimizeRx OPRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $10M-12.8% | ||
| $4.3M-0.7% | $4.33M-0.4% | $4.34M-0.3% | $4.36M0.0% | $4.36M+0.6% | ||
| —— | —— | —— | —— | —— | ||
| $6.84M+33.2% | $5.13M+14,994% | $34K+100% | -$9.87M+36.0% | -$15.41M+23.4% | ||
| —— | $368K-82.9% | $2.15M-45.3% | $3.93M-31.2% | $5.71M-23.8% | ||
| $1.29M+16.6% | $1.11M+3.4% | $1.07M-0.7% | $1.08M+30.7% | $827K-1.0% | ||
| —— | —— | —— | —— | —— | ||
| $1.85M+0.7% | $1.84M+47.4% | $1.25M+9.7% | $1.14M+713% | $140K-13.0% | ||
| —— | —— | —— | -$998K-158% | $1.72M+2,482% | ||
| —— | —— | —— | —— | $3.05M+40.6% | ||
| —— | —— | —— | $7.46M+229% | $2.27M+115% | ||
| —— | —— | —— | —— | $263.75K-12.4% | ||
| —— | —— | $15K+66.7% | $9K— | —— | ||
| —— | —— | —— | -$1.31M-1,441% | -$85K+89.5% | ||
| $3.86M-7.7% | $4.18M-22.4% | $5.39M-6.8% | $5.78M-3.2% | $5.97M-3.7% | ||
| -$10.92M-24.1% | -$8.8M-7.6% | -$8.17M+3.2% | -$8.45M-73.9% | -$4.86M+1.1% | ||
| $131K+92.6% | $68K+126% | -$258K+24.1% | -$340K+10.8% | -$381K+15.3% | ||
| $14.38M-23.1% | $18.72M+58.3% | $11.83M+13.5% | $10.41M+57.0% | $6.64M+35.7% | ||
| —— | —— | —— | $448K-47.8% | $858K-5.8% | ||
| $52K-10.3% | $58K-9.4% | $64K-11.1% | $72K-32.7% | $107K-4.5% | ||
| —— | —— | —— | $268K-2.2% | $274K-18.9% | ||
| $0— | $0-100% | $77K+1.3% | $76K0.0% | $76K-63.5% | ||
| $10.19M+27.4% | $8M0.0% | $8M0.0% | $8M+100% | $4M0.0% | ||
| $7.23M+3.9% | $6.96M-12.3% | $7.94M-7.5% | $8.59M-14.1% | $10M-12.8% | ||
| $18.5M+15.4% | $16.03M— | —— | —— | —— | ||
| $14.2M+21.3% | $11.71M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is OptimizeRx's revenue?
- OptimizeRx (OPRX) generated $107.3M in revenue over the trailing twelve months, up 39.8% year over year.
- Is OptimizeRx profitable?
- OptimizeRx reported $6.8M in net income over the trailing twelve months, a 6.4% net margin.
- What are OptimizeRx's profit margins?
- Gross margin is 70.0% and operating margin is 13.2%, with a 6.4% net margin.
- What is OptimizeRx's earnings per share?
- OptimizeRx's diluted EPS over the trailing twelve months is $0.35.
- Where does OptimizeRx's income statement data come from?
- Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
